Edition:
United States

OncoSec Medical Inc (ONCS.OQ)

ONCS.OQ on NASDAQ Stock Exchange Capital Market

1.70USD
1:23pm EST
Change (% chg)

$-0.04 (-2.30%)
Prev Close
$1.74
Open
$1.74
Day's High
$1.80
Day's Low
$1.69
Volume
58,083
Avg. Vol
317,359
52-wk High
$2.95
52-wk Low
$0.88

Latest Key Developments (Source: Significant Developments)

OncoSec Medical files for offering of up to 6.83 mln shares
Thursday, 16 Nov 2017 08:59am EST 

Nov 16 (Reuters) - Oncosec Medical Inc -:OncoSec Medical Inc files for offering of up to 6.83 million shares of co's common stock by the selling shareholders - SEC filing.  Full Article

Oncosec announces positive follow-up data from phase 2 trial of Immunopulse il-12
Wednesday, 8 Nov 2017 07:30am EST 

Nov 8 (Reuters) - Oncosec Medical Inc :Oncosec announces positive updated long-term follow-up data from phase 2 trial of Immunopulse il-12 in combination with pembrolizumab demonstrating a progression free survival rate (PFS) of 57% at 15 months in predicted anti-pd-1 non-responder melanoma p.  Full Article

Oncosec appoints Daniel O'Connor as CEO
Tuesday, 7 Nov 2017 05:04pm EST 

Nov 7 (Reuters) - Oncosec Medical Inc :Oncosec appoints Daniel J. O'Connor as chief executive officer to lead next stage of growth as a fully integrated late stage development and commercial company.Oncosec medical - ‍punit Dhillon, co-founder of Oncosec, will continue to serve as company's president and a member of its board​.  Full Article

Intracoastal Capital LLC reports 7.5 pct passive stake in OncoSec Medical
Tuesday, 31 Oct 2017 05:00pm EDT 

Oct 31 (Reuters) - OncoSec Medical Inc :Intracoastal Capital LLC reports 7.5 pct passive stake in OncoSec Medical Inc, as of October 22, 2017‍​.  Full Article

OncoSec Q4 loss per share $0.28
Wednesday, 25 Oct 2017 04:15pm EDT 

Oct 25 (Reuters) - OncoSec Medical Inc : :OncoSec announces fourth quarter and year end financial results for fiscal year 2017.Q4 loss per share $0.28.OncoSec medical - ‍expects current funds to be sufficient to allow co to continue to operate business to third calendar quarter of 2018​.  Full Article

Oncosec Q3 loss per share $0.22
Thursday, 1 Jun 2017 04:01pm EDT 

June 1 (Reuters) - Oncosec Medical Inc ::Oncosec announces third quarter and ytd results for fiscal year 2017.Q3 loss per share $0.22.Q3 earnings per share view $-0.28 -- Thomson Reuters I/B/E/S.  Full Article

Oncosec Q2 loss per share $0.27
Thursday, 16 Mar 2017 04:01pm EDT 

Oncosec Medical Inc : Oncosec announces second quarter and ytd results for fiscal year 2017 .Q2 loss per share $0.27.  Full Article

Oncosec granted FDA fast track designation for ImmunoPulse IL-12 for treatment of metastatic melanoma
Monday, 27 Feb 2017 06:01am EST 

Oncosec Medical Inc : Oncosec granted FDA fast track designation for immunopulse® IL-12 for the treatment of metastatic melanoma following progression on pembrolizumab or nivolumab .Says clinical trial is planned to initiate in first half of 2017.  Full Article

Oncosec Q4 loss per share $0.39
Thursday, 13 Oct 2016 04:01pm EDT 

Oncosec Medical Inc : Oncosec announces fourth quarter and year end results for fiscal year 2016 . Q4 loss per share $0.39 .Oncosec Medical Inc - Qtrly net loss $6.6 million versus $6.5 million.  Full Article

Oncosec posts Q3 loss per share $0.37
Thursday, 9 Jun 2016 04:01pm EDT 

Oncosec Medical Inc : Oncosec announces third quarter and YTD results for fiscal year 2016 . Q3 loss per share $0.37 .Expects funds to be sufficient to allow it to continue to operate its business for at least next 12 months.  Full Article

BRIEF-OncoSec Medical files for offering of up to 6.83 mln shares

* OncoSec Medical Inc files for offering of up to 6.83 million shares of co's common stock by the selling shareholders - SEC filing Source: (http://bit.ly/2hEfpJ6) Further company coverage: